Quantinuum (NASDAQ:QNT) Trading 11.5% Higher – Still a Buy?

Quantinuum Inc. (NASDAQ:QNT)’s share price traded up 11.5% on Wednesday . The company traded as high as $62.74 and last traded at $62.49. Approximately 618,515 shares traded hands during mid-day trading, a decline of 76% from the average daily volume of 2,620,271 shares. The stock had previously closed at $56.06.

Key Headlines Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Oracle partnership expands commercial reach: Quantinuum will deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure data center. Making Helios available as an OCI service could give enterprise, artificial-intelligence, academic, and research customers access to quantum computing without buying specialized hardware. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: Rapid revenue growth and higher outlook: Second-quarter revenue rose 279% year over year, and management raised its fiscal 2026 revenue outlook to $28 million-$32 million, above the roughly $26.6 million consensus estimate. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Analysts remain optimistic: Rosenblatt reaffirmed a Buy rating with a $155 price target, while Needham maintained Buy at $100 and Cantor Fitzgerald reiterated Overweight at $90. These targets imply substantial potential upside from recent trading levels.
• Positive Sentiment: Technology milestone supports the investment case: Quantinuum reported near five-nines logical fidelity on Helios, reinforcing its positioning in fault-tolerant quantum computing and potentially improving its appeal to commercial users. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Neutral Sentiment: Short-interest data offers little signal: Reported short interest was zero shares, making the stated short-interest ratio uninformative rather than a meaningful indicator of investor positioning.
• Negative Sentiment: Quarterly loss exceeded expectations: Quantinuum reported a loss of $0.28 per share versus the consensus loss estimate of $0.26, while quarterly revenue was $8 million. Continued losses and the early stage of quantum-computing commercialization remain key risks. Quantinuum earnings results

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on QNT shares. Wall Street Zen downgraded Quantinuum from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Sanford C. Bernstein boosted their price target on Quantinuum from $94.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price objective on shares of Quantinuum in a report on Wednesday. Jefferies Financial Group set a $85.00 price target on shares of Quantinuum in a research note on Wednesday. Finally, Evercore began coverage on Quantinuum in a research report on Monday, June 29th. They set an “outperform” rating and a $98.00 target price for the company. Twelve research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $98.42.

Quantinuum Stock Performance

The firm’s 50 day simple moving average is $62.71.

Quantinuum (NASDAQ:QNT) last announced its earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The company had revenue of $8.00 million for the quarter. On average, equities analysts predict that Quantinuum Inc. will post -1.61 EPS for the current year.

Insider Buying and Selling

In other Quantinuum news, Director Manish H. Bhatia purchased 20,000 shares of the business’s stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $60.00 per share, for a total transaction of $1,200,000.00. Following the acquisition, the director owned 25,833 shares of the company’s stock, valued at approximately $1,549,980. This represents a 342.88% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Joseph Jimenez acquired 66,665 shares of the stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $60.00 per share, with a total value of $3,999,900.00. Following the purchase, the director directly owned 72,498 shares in the company, valued at $4,349,880. This represents a 1,142.89% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 411,032 shares of company stock worth $24,661,920 over the last three months.

Institutional Investors Weigh In On Quantinuum

An institutional investor recently bought a new position in Quantinuum stock. Lisanti Capital Growth LLC acquired a new position in shares of Quantinuum Inc. (NASDAQ:QNT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,005 shares of the company’s stock, valued at approximately $409,000.

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.